The ODAC will weigh risk-benefit analyses from the FDA and sponsors on Keytruda, Opdivo, and Tevimbra when given with chemo in all comers and in PD-L1-positive subgroups.

Miplyffa treats Niemann-Pick disease type C, which progressively impacts the abilities to speak, swallow, and walk or move ...

EPIX READ THE FULL EPIX RESEARCH REPORT Business Update Masofaniten plus Enzalutamide Results in Increased rPFS On September ...

Findings showed comparable exposures to atezolizumab between Tecentriq Hybreza and intravenous atezolizumab. The confirmed ORR was 9% (95% CI, 5-13) in the Tecentriq Hybreza arm and 8% (95% CI, 4-14) ...

Objectives Cardiovascular disease is a leading cause of mortality in systemic lupus erythematosus (SLE). Frailty has been ...

In addition to other MM indications, Isatuximab's anti-CD38 competitor on the US market, daratumumab (Darzalex — Johnson & Johnson), also carries a first-line indication for transplant-ineligible MM ...

Two specialists are impressed by the preliminary findings of a randomized trial in newly diagnosed patients, but another is ...

A 50-year-old man was diagnosed with leprosy on pre-immigration screening in the Philippines and was prescribed oral dapsone and rifampin. He immigrated to Canada 1 month later and discontinued ...

or 10 cycles of docetaxel at 75 mg/m2 every 3 weeks plus 5 mg prednisone twice daily (arm B; n = 36). Upon disease ...

Detailed results from the TROPION-Lung01 Phase III trial showed a clinically meaningful trend toward improving overall survival (OS) with datopotamab ...

2024 MG HS. Photo: Supplied But the 1.5-litre turbo petrol engine gets all gruff when you demand a burst of speed, and that’s after the seven-speed dual clutch auto has a long hard think about p ...